Cellectar biosciences announces presentation of data on clr 12120 series of targeted alpha-emitting therapies at the 13th annual world adc conference

Preclinical data demonstrate ability to deliver targeted alpha-emitting isotopes to malignant cells and therapeutic efficacy preclinical data demonstrate ability to deliver targeted alpha-emitting isotopes to malignant cells and therapeutic efficacy
CLRB Ratings Summary
CLRB Quant Ranking